MICROCHIP TECHNOLOGY INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data MICROCHIP TECHNOLOGY INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	3,408	3,981	5,350	5,274	5,438	6,821	8,439	7,634	4,402	4,713
Cost of revenue	1,651	1,560	2,418	2,032	2,060	2,371	2,741	2,639	1,934	1,992
Gross profit	1,757	2,421	2,931	3,242	3,379	4,450	5,698	4,996	2,468	2,721
Research and development	545	529	826	878	836	989	1,118	1,097	984	1,086
Selling, general and administrative	500	452	683	677	610	719	798	734	618	674
Operating expenses	1,481	1,484	2,217	2,595	2,381	2,600	2,582	2,425	2,172	2,231
Operating income	276	936	714	647	998	1,850	3,116	2,571	296	490
Interest expense	146	199	503	497	357	257	204	198	259	221
Interest income	3.1	22	8.1	2.8	1.7	0.5	2.1	7.6	9.2	11.4
Other non-operating income	1.3	-5.8	-2.2	3.2	-3.8	2.8	3.8	-2.2	-5.7	-6.7
Pre-tax income	89.8	737	205	150	340	1,483	2,910	2,366	38.9	274
Income tax	-80.8	482	-151	-420	-9.9	197	672	459	39.4	43.5
Income from continuing operations	171	255	356
Net income to minority interests	0	0
Net income	165	255	356	571	349	1,286	2,238	1,907	-0.5	230
EBITDA	745	1,552	1,591	1,863	2,151	2,993	4,114	3,451	1,046	1,179
EPS, basic	0.38	0.55	0.75	1.19	0.67	2.33	4.07	3.52	-0.01	0.22
EPS, diluted	0.35	0.51	0.71	1.11	0.65	2.27	4.02	3.48	-0.01	0.22
Shares, basic (weighted)	436	468	475	478	519	552	550	542	537	540
Shares, diluted (weighted)	472	500	502	512	541	566	557	548	537	545
Dividend per share	0.72	0.72	0.73	0.73	0.75	0.91	1.26	1.68	1.82	1.82

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	909	901	429	401	280	317	234	320	772	240
Short-term investments	394	1,295	2.3	2	2	2	0
Receivables	478	564	881	934	998	1,073	1,305	1,144	690	895
Inventory	417	476	712	686	665	854	1,325	1,316	1,294	1,035
Other current assets	58.9	120	192	195	201	206	205	234	236	207
Total current assets	2,305	3,356	2,215	2,217	2,145	2,453	3,069	3,013	2,991	2,378
Property, plant and equipment	683	768	997	876	855	968	1,178	1,195	1,184	1,107
Lease right-of-use assets				120	154	153	154	156	146	138
Goodwill	2,299	2,299	6,664	6,665	6,671	6,674	6,674	6,675	6,685	6,696
Intangible assets	2,148	1,662	6,686	5,702	4,795	4,043	3,369	2,782	2,389	2,033
Long-term investments	108	0
Other non-current assets	75.1	71.8	112	217	264	265	457	612	398	364
Total assets	7,687	8,257	18,350	17,426	16,479	16,200	16,370	15,873	15,375	14,370
Accounts payable	149	144	226	247	292	345	397	213	161	206
Accrued liabilities	213	230	787	782	794	1,054	1,324	1,307	995	931
Deferred revenue	418	480				73.2	121	262	213	179
Short-term debt	50	1,310	1,361	609	1,323	0	1,398	999	0	0
Total current liabilities	705	2,017	2,375	1,637	2,410	1,399	3,119	2,519	1,155	1,136
Long-term debt	2,901	1,758	8,946	8,873	7,581	7,687	5,042	5,000	5,630	5,496
Lease liabilities				94.7	125	129	129	129	115	107
Other non-current liabilities	217	241	280	343	417	474	948	1,018	844	709
Total liabilities	4,416	4,977	13,063	11,841	11,142	10,305	9,857	9,215	8,296	7,938
Total debt	2,951	3,068	10,307	9,482	8,904	7,687	6,440	6,000	5,630	5,496
Paid-in capital	2,537	2,563	2,680	2,675	2,403	2,536	2,413	2,483	3,910	4,072
Retained earnings	1,479	1,397	3,211	3,432	3,394	4,175	5,764	6,760	5,781	4,916
Treasury stock	-732	-663	-582	-501	-434	-796	-1,660	-2,582	-2,612	-2,551
Other comprehensive income	-14.4	-17.6	-20.7	-21.6	-26.2	-20.6	-4.1	-3.5	-1.7	-4.2
Shareholders' equity	3,271	3,280	5,288	5,586	5,337	5,895	6,514	6,658	7,078	6,432
Total equity	3,271	3,280	5,288	5,586	5,337	5,895	6,514	6,658	7,078	6,432
Total liabilities and equity	7,687	8,257	18,350	17,426	16,479	16,200	16,370	15,873	15,375	14,370
Shares outstanding	460	472	477	245	547	555	545	537	539	542

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	165	255	356	571	349	1,286	2,238	1,907	-0.5	230
Depreciation and amortization	469	616	876	1,216	1,153	1,144	998	880	750	689
Stock-based compensation	128	93.2	166	170	198	210	170	178	180	255
Deferred income tax	-127	51.2	-62.2	-490	-139	7.9	206	-27.2	-143	-64.6
Change in receivables	-46.8	-85.3	239	-53.3	-63.7	-74.9	-233	162	454	-205
Change in inventory	224	-59.2	342	28.8	18.4	-178	-483	12.8	31.6	264
Change in payables	-14.8	-13.9	-181	11.4	17.6	193	323	-148	-346	26
Cash from operations	1,060	1,420	1,675	1,544	1,917	2,843	3,621	2,893	898	962
Capital expenditures	-10.2	-207	-229	-67.6	-92.6	-370	-486	-285	-126	-91.1
Acquisitions	0	0	-7,851	0	0
Purchases of investments	-500	-1,595	-168	-2	0	0
Sales and maturities of investments	0.4	787	78	4.7	0	0
Cash from investing	-2,838	-1,012	-6,811	-133	-173	-478	-600	-392	-288	-196
Debt issued	0	0	1,990	0	3,578	997	0	995	1,992	0
Debt repaid	0			0	0	-1,000	0	-3,400	-1,000	-1,200
Stock issued	42.2	42	42.6	58.8	60.3	70.5	82.3	82.1	65.4	61.7
Share buybacks	0	0		0	0	-426	-946	-982	-96.5	0
Dividends paid	-315	-338	-344	-350	-388	-504	-695	-912	-976	-984
Cash from financing	596	-415	4,664	-1,438	-1,864	-2,328	-3,105	-2,415	-158	-1,298
Exchange rate effect	-1	0	0
Net change in cash	-1,184	-7.4	-473	-27.6	-121	37.4	-83.4	85.7	452	-531
Free cash flow	1,049	1,213	1,446	1,476	1,824	2,473	3,135	2,608	772	871
Interest paid	82.5	85.3	348	355	265	208	182	191	236	211
Income taxes paid	48.4	25.9	77.6	101	87.3	141	483	517	175

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $78.69 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	60.2%	Gross profit / revenue.
Operating margin	15.5%	Operating income / revenue.
EBITDA margin	23.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	11.3%	Pre-tax income / revenue.
Net margin	9.3%	Net income / revenue.
FCF margin	21.7%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	23.4%	Cash from operations / revenue.
Effective tax rate	17.4%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	7.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	3.3%	Net income / average total assets.
Return on invested capital (ROIC)	5.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	22.2%	Research and development expense / revenue.
SG&A / revenue	13.7%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	5.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.7%	Capital expenditures / revenue.
D&A / revenue	7.9%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	7.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-17.6%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-2.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	10.3%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-21.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-4.2%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	65.4%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-46.0%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-13.3%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	12.7%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-34.1%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-11.3%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income CAGR, 3y	-53.2%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-8.0%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS CAGR, 3y	-62.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-19.5%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	7.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-35.7%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-12.9%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	12.8%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-34.7%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-13.7%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.2%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	13.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	19.5%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-9.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-0.4%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	3.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-6.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-4.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-2.7%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.7%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.92x	Current assets / current liabilities.
Quick ratio	0.96x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.21x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.83x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	37.2%	Total debt / total assets.
Liabilities / assets	55.2%	Total liabilities / total assets.
Net debt	$5.09B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	4.23x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	3.74x	Operating income / interest expense.
Working capital	$1.19B	Current assets - current liabilities.
Goodwill and intangibles / assets	60.4%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$2.25B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.36x	Revenue / average total assets.
Fixed asset turnover	4.72x	Revenue / average property, plant and equipment.
Inventory turnover	1.95x	Cost of revenue / average inventory.
Days inventory	187 days	365 x average inventory / cost of revenue.
Receivables turnover	5.29x	Revenue / average receivables.
Days sales outstanding	69 days	365 x average receivables / revenue.
Days payables	41 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	215 days	Days inventory + days sales outstanding - days payables.
FCF conversion	232.2%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	7.3%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.87	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$9.30	Revenue / diluted weighted shares.
FCF per share	$2.02	Free cash flow / diluted weighted shares.
Operating cash flow per share	$2.18	Cash from operations / diluted weighted shares.
Book value per share	$11.88	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$4.14	Tangible book value / shares outstanding.
Cash per share	$0.50	(Cash + short-term investments) / shares outstanding.
Payout ratio	206.0%	Dividends paid / net income, when net income is positive.
Dividends / FCF	88.7%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$42.73B	Share price x shares outstanding.
Enterprise value	$47.82B	Market cap + total debt - cash - short-term investments.
P/E	89.3x	Market cap / net income. Only when net income is positive.
P/S	8.34x	Market cap / revenue.
P/B	6.62x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	38.5x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	35.7x	Market cap / cash from operations, when positive.
EV/Sales	9.34x	Enterprise value / revenue.
EV/EBIT	60.2x	Enterprise value / operating income, when both are positive.
EV/EBITDA	39.8x	Enterprise value / EBITDA, when both are positive.
EV/FCF	43.0x	Enterprise value / free cash flow, when both are positive.
FCF yield	2.6%	Free cash flow / market cap.
Earnings yield	1.1%	Net income / market cap (the inverse of P/E).
Dividend yield	2.3%	Dividends paid over the period / market cap.
Shareholder yield	2.3%	(Dividends paid + share buybacks) / market cap.

What was MICROCHIP TECHNOLOGY INC's revenue in fiscal 2026?

MICROCHIP TECHNOLOGY INC reported revenue of $4.71B for fiscal 2026, 7.1% higher than the year before.

Was MICROCHIP TECHNOLOGY INC profitable in fiscal 2026?

Yes. Net income was $230.0M, a net margin of 4.9%.

How much free cash flow did MICROCHIP TECHNOLOGY INC generate in fiscal 2026?

Cash from operations of $962.1M minus capital expenditures of $91.1M left free cash flow of $871.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to MICROCHIP TECHNOLOGY INC